EGF RECEPTOR FUNCTION AND CONTROL BY PHOSPHORYLATION
EGF RECEPTOR FUNCTION AND CONTROL BY PHOSPHORYLATION
批准号:
2092768
负责人:
PAUL JOHN BERTICS
金额:
$12.13万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-08-01 至 1995-03-31
关键词:
DNA replication binding proteins cell growth regulation crosslink cytoskeleton enzyme mechanism enzyme substrate epidermal growth factor gel electrophoresis growth factor receptors high performance liquid chromatography hormone regulation /control mechanism human tissue immunoprecipitation phosphorylation point mutation protein kinase C scintillation spectrometry tissue /cell culture
中文摘要
有关细胞生长控制的分子机制的信息是
重要的是了解周围的正常发展的事件,
这些潜在的致癌作用。 表皮生长因子(EGF)是一种
配体刺激的蛋白酪氨酸激酶,经历快速EGF诱导
在其末端羧基-(C-)末端自我磷酸化。 的EGF
受体与逆转录病毒转化蛋白v-erbB同源,并且
它在某些人类肿瘤中过表达。 感兴趣的是两个一般
erbB突变增加其致癌能力:氨基末端
EGF结合位点的缺失,以及各种C-末端
截断。 在这方面,我们的初步研究显示,
C-末端自身磷酸化结构域的去除降低了高
亲和力结合,增加体内酪氨酸激酶活性并破坏
受体与细胞骨架的结合。 此外,这些和其他
研究强烈表明,受体C-末端结构域和
受体与细胞骨架的相互作用既可以控制
EGF受体结合和激酶活性 因为EGF受体激酶
活动是必要的适当的生物功能,以下
具体目标是:1)检查EGF的机制,
受体C末端调节蛋白酪氨酸激酶活性。 这些
研究将涉及底物特异性、动力学
机制和敏感性的蛋白激活剂正常和C-
表皮生长因子受体 2)EGF的作用
受体C-末端在促进细胞骨架附着,并确定
细胞骨架结合影响受体高亲和力的过程
结合和蛋白酪氨酸激酶活性。 这项工作将侧重于
C端结构域和蛋白激酶C激活对受体影响
细胞骨架分布,也将评估细胞骨架的影响,
对受体高亲和力结合、酪氨酸激酶活性和
底物特异性 3)识别和分析相关的特定蛋白质
在使用直接结合研究的EGF受体-细胞骨架缔合中,
以及免疫共沉淀和交联分析。 这些
预计经验将更严格地建立机制,
哪些特定的结构域,以及它们与细胞
细胞骨架,可以发挥关键作用,在调节EGF受体
在正常和异常细胞生长中起作用。
英文摘要
Information on the molecular mechanisms involved in cell growth control is
important for understanding the events surrounding normal development and
those underlying carcinogenesis. The epidermal growth factor (EGF) is a
ligand-stimulated protein-tyrosine kinase that undergoes rapid EGF-induced
self-phosphorylation in its extreme carboxy- (C-) terminus. The EGF
receptor is homologous to the retroviral transforming protein v-erbB, and
it is overexpressed in certain human tumors. Of interest are two general
mutations in erbB that increase its oncogenic capacity: an amino-terminal
deletion that removes the EGF binding site, and various C-terminal
truncations. In this regard, our initial studies have suggested that
removal of the C-terminal self-phosphorylation domain decreases high
affinity binding, increases tyrosine kinase activity in vivo and disrupts
receptor association with the cell cytoskeleton. Moreover, these and other
investigations strongly suggest that the receptor C-terminal domain and
receptor interaction with the cell cytoskeleton can both exert control over
EGF receptor binding and kinase activities. Because EGF receptor kinase
activity is essential for proper biological function, the following
specific aims are proposed: 1) Examine the mechanisms by which the EGF
receptor C-terminus regulates protein-tyrosine kinase activity. These
studies will involve an analysis of the substrate specificity, kinetic
mechanism and sensitivity to protein activators of both normal and C-
terminally mutated EGF receptors. 2) Characterize the role of the EGF
receptor C-terminus in promoting cytoskeletal attachment, and ascertain the
processes by which cytoskeletal association affects receptor high affinity
binding and protein-tyrosine kinase activity. This work will focus on the
influence of C-terminal domains and protein kinase C activation on receptor
cytoskeletal distribution, and will also asses the effects of cytoskeletal
association on receptor high affinity binding, tyrosine kinase activity and
substrate specificity. 3) Identify and analyze specific proteins involved
in the EGF receptor-cytoskeletal association using direct binding studies,
as well as co-immunoprecipitation and crosslinking analyses. These
experiences are expected to more rigorously establish the mechanisms by
which specific domains, and their interaction with the cellular
cytoskeleton, can play a key role in the regulation of EGF receptor
function in both normal and abnormal cell growth.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Potentiation of epidermal growth factor receptor protein-tyrosine kinase activity by sulfate.
硫酸盐增强表皮生长因子受体蛋白酪氨酸激酶活性。
DOI:
10.1016/0167-4889(92)90052-d
发表时间:
1992
期刊:
Biochimica et biophysica acta
影响因子:
--
作者:
[Hubler,L, Kher,U, Bertics,PJ]
通讯作者:
Bertics,PJ
Localization of epidermal growth factor receptors in first- and third-trimester human placentas.
表皮生长因子受体在妊娠早期和晚期人类胎盘中的定位。
DOI:
10.1177/42.7.8014474
发表时间:
1994
期刊:
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
影响因子:
--
作者:
[Duello,TM, Bertics,PJ, Fulgham,DL, VanEss,PJ]
通讯作者:
VanEss,PJ
Laminin responsiveness is associated with changes in fibroblast morphology, motility, and anchorage-independent growth: cell system for examining the interaction between laminin and EGF signaling pathways.
层粘连蛋白反应性与成纤维细胞形态、运动性和锚定无关生长的变化相关:用于检查层粘连蛋白和 EGF 信号通路之间相互作用的细胞系统。
DOI:
10.1002/jcp.1041640318
发表时间:
1995
期刊:
Journal of cellular physiology.
影响因子:
--
作者:
[Lin,ML, Bertics,PJ]
通讯作者:
Bertics,PJ
Activation of protein kinase C by selective binding of arginine-rich polypeptides.
通过选择性结合富含精氨酸的多肽来激活蛋白激酶 C。
DOI:
--
发表时间:
1993
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Leventhal,PS, Bertics,PJ]
通讯作者:
Bertics,PJ
Evidence for the potentiation of epidermal growth factor receptor tyrosine kinase activity by association with the detergent-insoluble cellular cytoskeleton: analysis of intact and carboxy-terminally truncated receptors.
通过与去污剂不溶性细胞骨架结合增强表皮生长因子受体酪氨酸激酶活性的证据:完整和羧基末端截短的受体的分析。
DOI:
10.1210/endo.133.6.8243311
发表时间:
1993
期刊:
Endocrinology
影响因子:
4.8
作者:
[Gronowski,AM, Bertics,PJ]
通讯作者:
Bertics,PJ
共 8 条
Signal Transduction Pathways in Eosinophil Priming
-
批准号:7843280
-
项目类别:
-
资助金额:$38.8万
-
财政年份:2009
-
负责人:PAUL JOHN BERTICS
-
依托单位:
Signal Transduction Pathways in Eosinophil Priming
-
批准号:7391415
-
项目类别:
-
资助金额:$38.78万
-
财政年份:2007
-
负责人:PAUL JOHN BERTICS
-
依托单位:
Molecular Analysis Using Liquid Crystal Technology
-
批准号:7603015
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2007
-
负责人:PAUL JOHN BERTICS
-
依托单位:
Molecular Analysis Using Liquid Crystal Technology
-
批准号:7240191
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2007
-
负责人:PAUL JOHN BERTICS
-
依托单位:
Molecular Analysis Using Liquid Crystal Technology
-
批准号:7418290
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2007
-
负责人:PAUL JOHN BERTICS
-
依托单位:
Rhinovirus Stimulation of Macrophage Signaling /Mediator
-
批准号:7151330
-
项目类别:
-
资助金额:$17.18万
-
财政年份:2006
-
负责人:PAUL JOHN BERTICS
-
依托单位:
IL-5 receptor activation and eosinophil signal transduction
-
批准号:6565042
-
项目类别:
-
资助金额:$19.62万
-
财政年份:2002
-
负责人:PAUL JOHN BERTICS
-
依托单位:
IL-5 receptor activation and eosinophil signal transduction
-
批准号:6630927
-
项目类别:
-
资助金额:$19.62万
-
财政年份:2002
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EFFECT OF INTERLEUKIN 5 RECEPTOR ACTIVATION ON EOSINOPHIL SIGNAL TRANSDUCTION
-
批准号:6410556
-
项目类别:
-
资助金额:$19.62万
-
财政年份:2000
-
负责人:PAUL JOHN BERTICS
-
依托单位:
IL 5 REGULATION OF EOSINOPHIL SIGNAL TRANSDUCTION AND FUNCTION
-
批准号:6340663
-
项目类别:
-
资助金额:$15.45万
-
财政年份:2000
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EFFECT OF INTERLEUKIN 5 RECEPTOR ACTIVATION ON EOSINOPHIL SIGNAL TRANSDUCTION
-
批准号:6302440
-
项目类别:
-
资助金额:$22.9万
-
财政年份:1999
-
负责人:PAUL JOHN BERTICS
-
依托单位:
IL 5 REGULATION OF EOSINOPHIL SIGNAL TRANSDUCTION AND FUNCTION
-
批准号:6201182
-
项目类别:
-
资助金额:$15.45万
-
财政年份:1999
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EFFECT OF INTERLEUKIN 5 RECEPTOR ACTIVATION ON EOSINOPHIL SIGNAL TRANSDUCTION
-
批准号:6110689
-
项目类别:
-
资助金额:$22.9万
-
财政年份:1998
-
负责人:PAUL JOHN BERTICS
-
依托单位:
IL 5 REGULATION OF EOSINOPHIL SIGNAL TRANSDUCTION AND FUNCTION
-
批准号:6099725
-
项目类别:
-
资助金额:$15.45万
-
财政年份:1998
-
负责人:PAUL JOHN BERTICS
-
依托单位:
IL 5 REGULATION OF EOSINOPHIL SIGNAL TRANSDUCTION AND FUNCTION
-
批准号:6235187
-
项目类别:
-
资助金额:$17.5万
-
财政年份:1997
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EFFECT OF INTERLEUKIN 5 RECEPTOR ACTIVATION ON EOSINOPHIL SIGNAL TRANSDUCTION
-
批准号:6273183
-
项目类别:
-
资助金额:$22.41万
-
财政年份:1997
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EFFECT OF INTERLEUKIN 5 RECEPTOR ACTIVATION ON EOSINOPHIL SIGNAL TRANSDUCTION
-
批准号:6242683
-
项目类别:
-
资助金额:$21.78万
-
财政年份:1996
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EGF RECEPTOR FUNCTION AND CONTROL BY PHOSPHORYLATION
-
批准号:3191707
-
项目类别:
-
资助金额:$7.93万
-
财政年份:1988
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EGF RECEPTOR FUNCTION AND CONTROL BY PHOSPHORYLATION
-
批准号:3191704
-
项目类别:
-
资助金额:$7.78万
-
财政年份:1988
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EGF RECEPTOR FUNCTION AND CONTROL BY PHOSPHORYLATION
-
批准号:2192614
-
项目类别:
-
资助金额:$14.66万
-
财政年份:1988
-
负责人:PAUL JOHN BERTICS
-
依托单位:
海外基金